|
26/01/2010
MHRA warns of counterfeit Alli dangers The MHRA has warned patients against buying medicines from unregulated websites after counterfeit Alli, containing unlicensed ingredient sibutramine rather than orlistat, was discovered in the US. The counterfeit Alli could be distinguished from the genuine product because the capsules were unmarked and contained white powder rather than small white pellets, the MHRA said. The fake medicine was also missing Lot codes on the end flap of the outer packaging and the inner foil safety seal did not have the words ‘sealed for your protection’ on it. The MHRA said it had not yet found the fake drug in the UK, but warned patients could still buy it online. MHRA head of Enforcement Mick Deats said: “Buying weight loss medication from unregulated websites is a dangerous way to slim down.” “You don’t know what you’re taking and your condition is not being monitored by a healthcare professional,” he added. To report a counterfeit medicine call the MHRA Counterfeit Hotline on 020 7084 2701 or email them here.
|
RELATED ARTICLES MHRA licencses Botox to treat chronic migraine > Slimming products don’t work, but weight loss clubs do > MHRA issues drug alert on Temozolomide Hospira recall > £150,000 counterfeit haul seized by MHRA > MHRA issues guidance on Alzheimer’s patch use > What the papers say: hospital morphine inquiry and pay people to lose weight > Slimming pills containing ephedrine sold illegally > RPSGB issues fresh warning over medicine shortages > Xrayser: Time to put a stop to the farce of shortages > Update Module 1475: Obesity management > |
|||